September 2006 - Australia Meeting

Program (preliminary)

The program will include lectures from international speakers, subproject overviews and poster presentations over the three days.

Friday September 22nd, 2006
Open all day	Registration And Poster Set-up
	Delegates are free for the morning to explore the Gold Coast and enjoy lunch on their own in local restaurants
Afternoon	Tour of Institute for Glycomics at Griffith University and Press Conference Hosts: Mark von Itzstein and Fiona Crone
18:00 – 19:30	Cocktail Reception at the Crowne Plaza Hotel
19:00 – 21:00	Buffet Dinner at the Crowne Plaza Hotel
19:00 – 21:00	Guest Speaker Introduction: Jeremy Carver

Saturday September 23rd, 2006
08:00 – 09:00	Registration and Poster Set-up
09:00 – 09:30	Introductory Remarks: Mark von Itzstein Welcoming Address: TBA
09:30 - 10:30	Keynote Speaker: Ralf Altmeyer
10:30 – 12:00	Theme 1 - Influenza Chair: Jeremy Carver, CEO ICAV
10:30 – 11:00	George Gao, Director-General, Institute of Microbiology, Chinese Academy of Sciences, China - Migratory birds and avian flu: an update
11:00 – 11:30	James Stevens, Scripps Research Institute, U.S.A. - Influenza Hemagglutinin Structure and Receptor Binding analysis using a Glycan Microarray
11:30 – 12:00	Coffee Break & Poster Viewing
12:00 - 12:30	Jennifer McKimm Breschkin, CSIRO Molecular and Health Technologies - Resistance to influenza virus neuraminidase inhibitors
12:30 - 13:00	Mark von Itzstein, Executive Director and Federation Fellow, Institute for Glycomics, Griffith University, Australia - Advances in the development of unsaturated uronic acid derivatives as influenza virus sialidase inhibitors
13:00 – 13:30	Philippe Buchy, Institut Pasteur, Cambodia
13:30 – 15:00	Delegates are free to enjoy lunch on their own in local restaurants
15:00 – 16:00	Theme 2 - Dengue Chair: Noël Tordo, Chef d'Unité, Institut Pasteur, Paris, France
15:00 – 15:30	Bruno Canard, Centre National de la Recherche Scientifique
15:30 – 16:00	Paul Young, University of Queensland, Australia - Flavivirus Targets In Antiviral Drug Design
16:00 – 16:30	Kazuya Hidari, University of Shizuoka, Japan, Visiting Scientist, Institute for Glycomics, Griffith University, Australia - Effect of synthetic carbohydrate derivatives on dengue virus infection
17:00 – 17:30	Coffee Break & Poster Viewing
17:30 – 18:30	Theme 3 - Chikungunya and Ebola Chair: Nabil Seidah, Director, Laboratory of Biochemical Neuroendocrinology, Institut de recherches cliniques de Montréal (IRCM), Canada
17:30 – 18:00	Pierre-Olivier Vidalain, Institute Pasteur, France - Large-scale mapping of virus-host protein-protein interactions using high-throughput yeast two-hybrid. New prospects for the characterization of Chikungunya virus.
18:00 – 18:30	Ute Stroeher, Canadian Science Centre for Human and Animal Health, Canada - Recombinant VSV- the Magic Bullet for Post Exposure Treatment
19:30 – 21:00	Reception Revolving Restaurant at the Crowne Plaza

Sunday, September 24th, 2006
09:00 – 10:30	Theme 4 – Novel Targets for HIV/AIDS Chair: Michel Chrétien, Program Director, Ottawa Health Research Institute, Canada
09:00 – 09:30	Vanessa B Soros, Gladstone Institute of Virology and Immunology, U.S.A. - Enabling APOBEC3G Innate Immunity Against HIV
09:30 – 10:00	Annapurna Vyakarnan, Department of Infectious Diseases, King's College, London, U.K. - G9: a novel HIV regulatory protein with therapeutic potential
10:00 – 10:30	Jeroen Mesters: University of Luebeck, Germany, - Structural evolution of Ritonavir Resistance in HIV-1 Proteinase
10:30 – 11:00	Coffee Break & Poster Viewing
11:00 – 12:30	Theme 5 – Rotavirus Chair: Mark von Itzstein
11:00 – 11:30	Barbara Coulson, Senior Research Fellow, NHMRC Head, Rotavirus Laboratory Department of Microbiology and Immunology, University of Melbourne, Australia - Potential targets for anti-viral drugs provided by rotavirus interactions with host cells
11:30 – 12:00	Helen Blanchard, Research Leader, Institute for Glycomics, Griffith University, Australia - Structural investigation of the rotavirus spike protein carbohydrate-recognising domain VP8* from sialidase sensitive and insensitive strains.
12:00 – 12:30	Thomas Haselhorst, Institute for Glycomics, Griffith University, Australia - On the road to novel rotavirus entry inhibitors – A NMR structure-based drug design approach
13:30 – 14:00	Catered Lunch & Poster Viewing
14:00 – 17:30	Focus: Approaches to Drug Discovery Chair: Rolf Hilgenfeld
14:00 – 14:30	Ralf Altmeyer, Singapore
14:30 – 15:00	Simon Tucker, Biota Holdings Limited, Australia
15:00 – 15:30	Patrick Labonté, INRS-Institut Armand-Frappier, Canada - Targeting HCV replication
15:30 - 16:00	Coffee break
16:00 – 16:30	Stephanie Pollock, University of Oxford, U.K. - Novel strategies for the development of antivirals against HIV and HCV
16:30 – 17:00	J. M. Garcia, Institute Pasteur, Hong Kong - Identification of Novel Anti-HIV Inhibitors by High-Throughput Screen of an Original Library of Pure Chemical Compounds
17:00 – 17:30	Eleanor Fish, Division of Cellular & Molecular Biology Toronto General Research Institute, Canada - Broad-Spectrum Antiviral Strategy: Proof of Principle
17:30 - 18:00	Philip Bernstein, Institute Pasteur, Korea - A Systems Biology Approach to Drug Discovery
18:30 – 20:00	Dinner - Australian Outback Spectacular

Monday, September 25th, 2006
09:00 – 16:00	Focus: ICAV Subproject Updates Chair: Jeremy Carver
09:00 – 09:30	Protease subproject (Rolf Hilgenfeld, Richard Kao, Robert Ménard)
09:30 – 10:00	Polymerase subproject (Bruno Canard, Noël Tordo)
10:00 – 10:30	Coffee Break
10:30 – 11:30	Neuraminidase subproject (Mark von Itzstein, Igor Tvorska, Robert Ménard, Jonathan Cechetto)
12:00 – 14:00	Lunch
14:00 – 15:00	Convertase subproject (Nabil Seidah, Michel Chrétien, Patrick Labonté, Mario Pinto, Emil Pai, Robert Ménard, Jonathan Cechetto)
	Discussion
15:30 – 16:00	Coffee Break
16:00 – 17:00	Plenary Summary Chair: Jeremy Carver: Q & A Next Steps
17:00	Closing Remarks Departure